Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo

Hepatology

Volumn 23, Issue 2, 1996, Pages 366-371

  Zeuzem, Stefan ^a   Schmidt, Jürgen M ^b   Lee, Jung Hun ^a   Rüster, Brigitte ^c   Roth, W Kurt ^c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; HEPATITIS C ANTIBODY; RECOMBINANT ALPHA INTERFERON; VIRUS RNA;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HALF LIFE TIME; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS REPLICATION;

EID: 0030039045     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008591865     Document Type: Article

References (28)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
2. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-1905.
3. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466.
4. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Aead Sci U S A 1990;87:6547-6549.
5. Davis GL, Baiart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. N Engl J Med 1989;321:1501-1506.
6. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, et al. Recombinant interferon alfa therapy for chronic hepatitis C. N Engl J Med 1989;321:1506-1510.
7. Lau JYN, Mizokami M, Ohno T, Diamond DA, Kniffen J, Davis GL. Discrepancy between biochemical and virological responses to interferon-α in chronic hepatitis C. Lancet 1993;342:1208-1209.
8. Joklik WK. Interferons. In: Fields BM, ed. Virology. Ed 2. New York: Raven, 1990:383-410.
9. Gutterman JU. Cytokine therapeutics: lessons from interferon α. Proc Natl Acad Sci U S A 1994;91:1198-1205.
10. Rüster B, Zeuzem S, Roth WK. Quantification of hepatitis C virus RNA by competitive reverse transcription and polymerase chain reaction using a modified hepatitis C virus RNA transcript. Anal Biochem 1995;224:597-600.
11. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-2399.
12. Van de Peer Y, De Wachter R. Treecon for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput Applic Biocsi 1994;10:569-570.
13. Kimura M. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980;16:111-120.
14. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987;4:406-425.
15. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985;39:783-791.
16. Neider JA, Mead R. A simplex method for function minimization. Comput J 1965;7:308-313.
17. Johnson ML. Evaluation and propagation of confidence intervals in nonlinear, asymmetrical variance spaces: analysis of ligand-binding data. Biophys J 1983;44:101-106.
18. Waits DG. Parameter estimates from nonlinear models. In: Johnson ML, Brand L, eds. Methods Enzymol 1994;240:23-36.
19. Sokal RR, Rohlf FJ. Biometry - statistical tables. Ed 2, New York: WH Freeman & Co, 1981.
20. Press WH, Flannery BP, Teukolsky SA, Vetterling WT. Numerical recipes. Cambridge: Cambridge University Press, 1989.
21. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-122.
22. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-126.
23. Chemello L, Alberti A, Rose K, Simmonds P. Hepatitis C serotype and response to interferon therapy. N Engl J Med 1994;330:143.
24. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus. HEPATOLOGY 1992;16:293-299.
25. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, et al. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. HEPATOLOGY 1994;19:1088-1094.
26. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. J Clin Invest 1995;96:224-230.
27. Lau JYN, Davis GL, Kniffen J, Qian K-P, Urdea MS, Chan CS, Mizokami M, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501-1504.
28. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, et al. Immunohistochemical detection of fas antigen in liver tissue of patients with chronic hepatitis C. HEPATOLOGY 1994;19:1354-1359.